Home
Our Technology
Innovative Chemistry
Transformative Therapies
FDA “Fast Track” and “Breakthrough Therapy” designations received.
About us
What We Do
We’re a biotech company committed to stemming the prescription drug abuse epidemic.
Our Strategy
Delivering
Innovative Technology
-
TAAP™ Preventing drug abuse
A highly novel platform that reduces the possibility of abuse by snorting, extracting, injection or chewing.
-
Universal Application
Our technology can be applied to a large complement of oral prescription drugs
-
MPAR® Preventing drug overdose
Our unique Multi-Pill Abuse Resistant technology MPAR® provides another layer of protection, reducing the possibility of overdose.
Our Team
Brilliant minds
and vision
We’re proud to say our team is made up of just that — people and minds both driven by passion and full of potential. Our company is led by a team of executives and directors with vast experience and proven track records in pain, drug development and commercialization.
D. Lynn Kirkpatrick, PhD
Chief Executive Officer
Dave Humphrey
Chief Financial Officer
Bill Schmidt, PhD
Chief Medical Officer.
Geoff Birkett
Chief Commercial Officer
